Review Article
Hepatitis C Virus Infection and Dialysis: 2012 Update
Table 2
Pegylated IFN plus ribavirin in dialysis patients: baseline characteristics and outcomes of studies.
| | Authors | SVR
| Country | Reference year |
| | Bruchfeld et al. | 50% (3/6) | Sweden | 2006 | | Rendina et al. | 97.5% (34/35) | Italy | 2007 | | van Leusen et al. | 71% (5/7) | Netherlands | 2008 | | Carriero et al. | 28% (4/14) | US | 2008 | | Al-Saran et al. | 70% (7/10) | Saudi Arabia | 2009 | | Hakim et al. | 5% (1/20) | US | 2009 | | Liu et al. | 60% (21/35) | Taiwan | 2009 | | Giguere et al. | 73% (16/22) | Arab Emirates | 2011 | | Deltenre et al. | 50% (16/32) | France | 2011 |
|
|
Results have been calculated according to an intention-to-treat (ITT) analysis.
SVR: sustained virological response.
|
